• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VERYAN MEDICAL BIOMIMICS 3D VASCULAR STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VERYAN MEDICAL BIOMIMICS 3D VASCULAR STENT SYSTEM Back to Search Results
Catalog Number 131816-06
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Reocclusion (1985); Claudication (2550)
Event Date 09/23/2019
Event Type  Injury  
Manufacturer Narrative
There was no reported device malfunction and the device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of claudication and occlusion/restenosis are listed in the biomimics 3d instructions for use and are known patient effects of peripheral stenting procedures.There is no indication of a product quality issue with respect to the design, manufacture or labelling of the device.If further information regarding this event becomes available a follow-up report will be submitted.
 
Event Description
The patient was treated as part of the (b)(6) study on (b)(6) 2017.At index procedure ((b)(6) 2017), the patient presented with a de-novo occlusion between the distal third of the superficial femoral artery (sfa) and the proximal popliteal artery of the left leg.A 6.0 x 80 mm biomimics 3d stent was implanted.On (b)(6) 2019 a restenosis of the treated segment (target lesion) was reported to veryan with a date of on set of (b)(6) 2019.On (b)(6) 2019 the patient had a percutaneous intervention on the treated segment.This included bare metal stent, percutaneous transluminal angioplasty / standard balloon angioplasty and thrombectomy.The outcome of the event is that it has resolved and patient has recovered.The device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOMIMICS 3D VASCULAR STENT SYSTEM
Type of Device
BIOMIMICS 3D VASCULAR STENT SYSTEM
Manufacturer (Section D)
VERYAN MEDICAL
unit 11 galway technology park
parkmore
galway city, H91 V E0H
EI  H91 VE0H
Manufacturer Contact
judy calt
unit 11 galway technology park
parkmore
galway city, H91 V-E0H
EI   H91 VE0H
MDR Report Key9213773
MDR Text Key163561567
Report Number3011632150-2019-00108
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P180003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Reporter Occupation Physician
Type of Report Initial
Report Date 10/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/21/2019
Is this an Adverse Event Report? Yes
Device Operator No Information
Device Expiration Date01/31/2017
Device Catalogue Number131816-06
Device Lot Number287365
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/24/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/06/2015
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age63 YR
Patient Weight115
-
-